NO180568C - Fremgangsmåte for å isolere en hovedsakelig ren anti-inflammatorisk faktor fra melk - Google Patents

Fremgangsmåte for å isolere en hovedsakelig ren anti-inflammatorisk faktor fra melk

Info

Publication number
NO180568C
NO180568C NO894784A NO894784A NO180568C NO 180568 C NO180568 C NO 180568C NO 894784 A NO894784 A NO 894784A NO 894784 A NO894784 A NO 894784A NO 180568 C NO180568 C NO 180568C
Authority
NO
Norway
Prior art keywords
milk
isolating
substantially pure
inflammatory factor
pure anti
Prior art date
Application number
NO894784A
Other languages
English (en)
Norwegian (no)
Other versions
NO894784L (no
NO894784D0 (no
NO180568B (no
Inventor
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NO894784D0 publication Critical patent/NO894784D0/no
Publication of NO894784L publication Critical patent/NO894784L/no
Publication of NO180568B publication Critical patent/NO180568B/no
Publication of NO180568C publication Critical patent/NO180568C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO894784A 1988-04-04 1989-11-30 Fremgangsmåte for å isolere en hovedsakelig ren anti-inflammatorisk faktor fra melk NO180568C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/177,223 US4956349A (en) 1983-10-27 1988-04-04 Anti-inflammatory factor, method of isolation, and use
PCT/US1989/001122 WO1989009602A1 (fr) 1988-04-04 1989-03-20 Facteur anti-inflammatoire, procede d'isolation, et utilisation

Publications (4)

Publication Number Publication Date
NO894784D0 NO894784D0 (no) 1989-11-30
NO894784L NO894784L (no) 1990-02-01
NO180568B NO180568B (no) 1997-02-03
NO180568C true NO180568C (no) 1997-05-14

Family

ID=22647713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894784A NO180568C (no) 1988-04-04 1989-11-30 Fremgangsmåte for å isolere en hovedsakelig ren anti-inflammatorisk faktor fra melk

Country Status (19)

Country Link
US (1) US4956349A (fr)
EP (1) EP0336694B1 (fr)
JP (1) JP2834244B2 (fr)
KR (1) KR0131014B1 (fr)
AT (1) ATE124628T1 (fr)
AU (1) AU620289B2 (fr)
CA (1) CA1339724C (fr)
DE (1) DE68923310T2 (fr)
DK (1) DK175473B1 (fr)
ES (1) ES2073434T3 (fr)
FI (1) FI98269C (fr)
GR (1) GR3017509T3 (fr)
IE (1) IE69395B1 (fr)
IL (1) IL89741A (fr)
MX (1) MX165968B (fr)
NO (1) NO180568C (fr)
NZ (1) NZ228587A (fr)
PH (1) PH27076A (fr)
WO (1) WO1989009602A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5814345A (en) * 1982-06-03 1998-09-29 Stolle Research & Development Corporation Immune suppressive product
US6054124A (en) * 1982-06-03 2000-04-25 Stolle Milk Biologics, Inc. Immune suppressive product
DE3829552A1 (de) * 1988-08-31 1990-03-01 Gauri Kailash Kumar Milchbestandteile, verfahren zu ihrer herstellung und mittel, die diese bestandteile enthalten
EP0646017A1 (fr) * 1990-07-05 1995-04-05 The Stolle Research And Development Corporation Produit immunosuppresseur
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5453444A (en) * 1992-10-13 1995-09-26 Otsuka Pharmaceutical Co., Ltd. Method to mitigate or eliminate weight loss
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
EP0743060B1 (fr) * 1995-04-28 2002-11-13 Sara Lee/DE N.V. Utilisation de produits d'hygiène dentaire comprenant du colostrum bovin
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6468534B1 (en) * 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility
TWI454268B (zh) * 2008-07-04 2014-10-01 Stolle Internat Co Ltd 乳汁萃取物做為降低過敏反應的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
NL7413874A (nl) * 1973-10-26 1975-04-29 Nat Res Dev Werkwijze voor het bereiden van stoffen tegen ontstekingen.
CH590064A5 (fr) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
JPS6043333B2 (ja) * 1976-08-20 1985-09-27 三共株式会社 抗炎症活性物質の製法
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
US4402938A (en) * 1980-05-29 1983-09-06 Impro Products, Inc. Food and the method of extracting the same from colostrum and milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
JP2561234B2 (ja) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション 抗炎症剤
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
EP0300102B1 (fr) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Méthode d'obtention de facteurs immunorégulateurs par immunisation de mammifères

Also Published As

Publication number Publication date
KR0131014B1 (ko) 1998-04-17
ES2073434T3 (es) 1995-08-16
GR3017509T3 (en) 1995-12-31
NO894784L (no) 1990-02-01
HK1007511A1 (en) 1999-04-16
US4956349A (en) 1990-09-11
FI98269C (fi) 1997-05-26
WO1989009602A1 (fr) 1989-10-19
JPH02503802A (ja) 1990-11-08
IE69395B1 (en) 1996-09-18
EP0336694A2 (fr) 1989-10-11
EP0336694B1 (fr) 1995-07-05
CA1339724C (fr) 1998-03-17
ATE124628T1 (de) 1995-07-15
IE891056L (en) 1989-10-04
DE68923310T2 (de) 1996-01-11
PH27076A (en) 1993-02-01
DK610389A (da) 1989-12-04
EP0336694A3 (en) 1990-05-16
NZ228587A (en) 1991-12-23
DK610389D0 (da) 1989-12-04
IL89741A0 (en) 1989-09-28
FI98269B (fi) 1997-02-14
DK175473B1 (da) 2004-11-08
MX165968B (es) 1992-12-14
AU3343789A (en) 1989-11-03
IL89741A (en) 1994-07-31
NO894784D0 (no) 1989-11-30
KR900700111A (ko) 1990-08-11
AU620289B2 (en) 1992-02-13
NO180568B (no) 1997-02-03
DE68923310D1 (de) 1995-08-10
FI895751A0 (fi) 1989-12-01
JP2834244B2 (ja) 1998-12-09

Similar Documents

Publication Publication Date Title
NO180568C (no) Fremgangsmåte for å isolere en hovedsakelig ren anti-inflammatorisk faktor fra melk
IL119549A0 (en) Trehalose
FR2607322B1 (fr) Procede de croissance epitaxiale d'un compose semi-conducteur
IT1177344B (it) Impianto per la produzione automatica di lenti organiche
DK0548123T3 (da) Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelse
FR2724857B1 (fr) Procede de fabrication d'aubes cristallines
ATE30729T1 (de) Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.
OA08907A (en) Process for polymorphic crystalline form conversion.
HU9203689D0 (en) Method for fish breeding
FR2629347B1 (fr) Procede de preparation d'un serum antilymphocytaire par immunisation d'animaux a l'aide d'un clone de lymphoblaste t humain, et serum antilymphocytaire ainsi obtenu
ATE54148T1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
ATE5077T1 (de) 22-arylsulfonyl-24,25-dihydroxy-cholestane und verfahren zu ihrer herstellung.
FR2545320B1 (fr) Procede pour ameliorer la croissance des plantes par eclairement intermittent
FR2612512B1 (fr) Procede d'oxydation de composes organiques par l'eau oxygenee en presence d'un catalyseur
AT373892B (de) Verfahren zur herstellung des neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin
CA2105861A1 (fr) Technique de production de poisson
IT8767814A0 (it) Macchina mietitrebbiatrice con dispositivo per il controllo dal posto di guida del prodotto che viene riciclato nel gruppo battitore del la macchina per una seconda trebbiatura
DE69411660D1 (de) Vorrichtung zur Herstellung von Silizium-Einkristallen durch das Czochralski-Verfahren
IT8347715A0 (it) Me per la zootecnia alternativa procedimento per produrre un mangiadatto per l'allevamento dei lombrichi
GR3006030T3 (fr)
RO89229A2 (fr) Procede d'obtention des esters epoxy dispersables dans l'eau applicables par electrodepot anodique
CS192437B1 (en) Method of production of the feeding protein concentrate from the soft tannery refuse
FR2614500B1 (fr) Module d'acidification pour la fabrication de fromages
FR2490294B1 (fr) Procede de fabrication d'un collier de serrage et collier de serrage obtenu par ce procede
ATE100140T1 (de) Herstellung von schimaeren antikoerpern durch homologe rekombination.